References
- Ordonez NG. The immunohistochemical diagnosis of mesothelioma. Differentiation of mesothelioma and lung adenocarcinoma. Am J Surg Pathol 1989;13: 276-91
- Song HK, Park SI, Cho KH, Kim WY, Chung CK, Oh HK, et al. Clinical review on two cases of pleural mesothelioma. Tuberc Respir Dis 1977;24:158-63
- Kwon C, Kim HG, Rhee YK. A case of malignant mesothelioma with pleural effusion. Tuberc Respir Dis 1983;30:219-26
- Lee MC, Cho CH, Kim SK, Chang J, Kim SK, Lee WY, et al. A case of malignant mesothelioma of pleura associated with hypoglycemia. Tuberc Respir Dis 1990;37:428-33
- Shim TS, Kim HJ, Choe HS, Lee HP, Seo JY, Kim YW, et al. Clinical study on mesothelioma of the pleura. Tuberc Respir Dis 1991;38:135-42
- Park MI, Choi JS, Choi HM, Jang TI, Moon IH, Kim JH, et al. A case of diffuse malignant pleural mesothelioma with occupational asbestos exposure. Korean J Intern Med 1995;48:526-30
- Oh YW, Kim HS, Kim JH, Chung KB, Suh WH. Differentiation between malignant pleural mesothelioma and metastasis of the pleura: CT evaluation. Korea Univ Med J 1997;34:25-9
- Kang DM, Kim JW, Son BC, Kim JI, Woo JC, Lee JT. A case of malignant pleural mesothelioma combined with asbestosis in a boilermaker and plumber. Korean J Occup Environ Med 1998;10:610-7
- Oh HK, Ro JY, Yoon CJ, Chi JG. Analysis of pulmonary asbestos body in malignant mesothelioma. Korean J Pathol 1999;33:361-6
- Kwon JB, Park CB, Kim JH, Kim KH, Park GH, Won YS, et al. Malignant mesothelioma with hypoglycemia. Korean Thorac Cardiovasc Surg 2000;33:978-81
- Wagner JC, Sleggs CA, Marchand P. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med 1960;17:260-71
- Sebastien P, Janson X, Gaudichet A, Hirsch A, Bignon J. Asbestos retention in human respiratory tissues: comparative measurements in lung parenchyma and in parietal pleura. IARC Sci Publ 1980;30:237-46
- Zanella CL, Posada J, Tritton TR, Mossman BT. Asbestos causes stimulation of the extracellular signal-regulated kinase 1 mitogen-activated protein kinase cascade after phosphorylation of the epidermal growth factor receptor. Cancer Res 1996;56:5334-8
- Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 2003;21:2636-44 https://doi.org/10.1200/JCO.2003.11.136
- Nowak AK, Byrne MJ, Williamson R, Ryan G, Segal A, Fielding D, et al. A multicentre phase II study of cisplatin and gemcitabine for malignant mesothelioma. Br J Cancer 2002;87:491-6 https://doi.org/10.1038/sj.bjc.6600505